Nina Bhardwaj

Director/Board Member at

Cancer Research Institute

Health Services

Commercial Services

Health Technology

Profile

Nina Bhardwaj is currently a Member of the Scientific Advisory Council at the Cancer Research Institute.
She previously held positions as a Member of the Board of Directors at the American Association for Cancer Research, Director at the American Association for Cancer Research, and Member of the Scientific Advisory Board at CTx Operations, Inc.

Nina Bhardwaj active positions

Companies	Position	Start
Cancer Research Institute Cancer Research Institute Medical/Nursing ServicesHealth Services Provides cancer immunotherapy services	Director/Board Member	-

All active positions of Nina Bhardwaj

Former positions of Nina Bhardwaj

Companies	Position	End
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Director/Board Member	-
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer	Corporate Officer/Principal	-

See the detail of Nina Bhardwaj's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nina Bhardwaj's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Cancer Research Institute Cancer Research Institute Medical/Nursing ServicesHealth Services Provides cancer immunotherapy services	Health Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer	Health Technology